FertilAI is developing AI algorithms designed to increase the success rates of fertility treatments, with an emphasis on improving the complicated workflows between doctors and patients.
Based on clinical research performed by the FertilAI team, the first such algorithm used for natural cycle ovulation prediction has already been developed and is in the process of receiving CE regulation.
FertilAI was recently approved for a grant from the Israeli Innovation Authority to develop a first pilot site.
Cumulative Funding Raised Over Time ($)
Employees Over Time
FertilAI Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Apr 15, 2026
www.prnewswire.com
/PRNewswire/ -- FertilAI has received CE marking under the EU Medical Device Regulation (EU MDR) for its AI-driven clinical decision support tools. To the...
/PRNewswire/ -- FertilAI has received CE marking under the EU Medical Device Regulation (EU MDR) for its AI-driven clinical decision support tools. To the...